Delivery Order SPE2DB20D1100-SPE2DB24FC3Y1

Award Date 6/21/24
Potential Completion Date 6/24/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $10,840.29 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563716172 CONCERTA ER 27 MG TABLET 100S, with a completion date of February 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $33,159.58 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide CONCERTA ER 27 MG TABLET 100S. The contract has an ultimate completion date of September 16, 2024 and is not set aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support...
This is a $6,842.75 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CONCERTA ER 27 MG tablets. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a range of medical commodities to support military...
This $10,384.68 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100 units of CONCERTA ER 27 MG tablets, a prescription drug product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a wide range of medical commodities to support military...
This is a $3,970.53 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CONCERTA ER 27 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of August 14, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the supply of a wide range of pharmaceutical and...
This is a federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,701.91 firm fixed-price delivery order is for the supply of CONCERTA ER 27 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONCERTA ER 27 MG TABLET 100S. The contract has a firm fixed price of $1,580.06 and an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the delivery of 4,565,585,879 units of CONCERTA ER 27 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $5,922.55 and an ultimate completion date of August 27, 2024. This contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract is a Firm Fixed Price arrangement,...
This is a $33,429.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CONCERTA ER 36 MG TABLET 100S and has a completion date of May 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,708.25 firm fixed-price delivery order is for the supply of 4,566,629,103 units of CONCERTA ER 54 MG TABLET 100S. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3Y1
    Delivery Order

This $10,262.98 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 21, 2024. The contract is for the supply of 4564977285 CONCERTA ER 27 MG TABLET 100S, a pharmaceutical product. The award has an ultimate completion date of June 24, 2024 and was not set aside for any particular business type.

AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 10:10 AM